Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of midazolam co-induction to general anesthesia
DRKS00024564Phase 4Completed
- Sponsor
- University Clinical Hospital Mostar
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam in Postprocedural endocrine and metabolic disorder and hypertension (HTN) (3 arms), sponsored by University Clinical Hospital Mostar. Started Aug 2021; status: completed.
02
Drugs
midazolam
03
Conditions
Postprocedural endocrine and metabolic disorderhypertension (HTN)
Beyond the preview
Go deeper on DRKS00024564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024564.